Uncategorized Archives - Page 5 of 221

ThursdayMay 16, 2024 10:00 am

Canadian Uniform Maker, Hemp Processor Receive $4.5M to Make Textiles

Financing amounting to $4.5 million has been availed to bolster the supply chain of hemp through the production of uniforms in Alberta, Canada. Of this amount, $3.65 million will be provided to Askiy Hemp LP by the Canadian federal government. Askiy has plans to set up an industrial plant to process industrial hemp within Elk Point. In addition, the provincial government of Alberta will inject $804,000 in Logistik Unicorp, a company that makes uniforms. The intention of this initiative is to convert locally grown hemp in Frog Lake and Elk Point into a variety of products, starting with textiles. Indigenous…

TuesdayMay 14, 2024 10:00 am

Illinois Lawmakers Want More Oversight of Hemp Industry

Lawmakers in Illinois are calling for increased oversight over the state’s largely unregulated hemp derivatives market. This market ballooned in the years after the 2018 Farm Bill legalized industrial hemp and hemp extracts across the United States under state and tribal programs. In the wake of this legislation, many businesses took advantage of legal loopholes to process and sell hemp derivatives such as cannabidiol (“CBD”), and delta-8 THC. While these derivatives technically aren't illegal under federal law, there are few if any federal or state regulations governing their production and sale. As a result, Illinois and other states with hemp…

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

ThursdayMay 09, 2024 10:00 am

USDA Data Shows Hemp Acreage Shrinking in Midwest

A recent report authored by the U.S. Department of Agriculture indicates that the quantity of hemp being cultivated by farmers in the Great Plains and Midwest region of the country has reduced in comparison to what it was two years prior. However, one research experts sees this reduction as something good. David Lakeman, head of the department of agriculture in Illinois, says the explosive interest in growing hemp after the enactment of the 2018 Farm Bill through which hemp was legalized resulted in the value chain for the plant being overwhelmed. He notes that there was a need to establish…

ThursdayMay 09, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance

Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per…

TuesdayMay 07, 2024 3:00 pm

Missouri Issues Health Advisory on Hemp-Sourced Cannabinoids

Residents of Missouri are being warned against the purchase and consumption of products that contain cannabinoids derived from hemp. This isn’t the first time the state’s health and senior services department has warned Missourians of the dangers of these cannabinoids. Recently, the department reported a substantial increase in poisonings linked to marijuana consumption. The consumption of cannabinoids derived from hemp can cause dizziness, nausea, vomiting, cognitive impairment, loss of consciousness, tremors, hallucinations, anxiety and, in rare cases, death. By their name, one can deduce that these compounds are processed from hemp and contain psychoactive compounds. The compounds include delta-6 THC,…

TuesdayMay 07, 2024 11:15 am

Golden Triangle Ventures Inc. (GTVH) New Acquisition Takes Lavish Division One Step Closer to Development of Premier Music, Art Destination

More than half of Americans have attended a music festival, indicating lucrative potential for music and art destinations GTVH recently closed on the acquisition of ABI Create, a premier event-management and production company With the invaluable resources ABI Create brings to the table, the future of Destino Ranch looks more promising than ever With Coachella still fresh in music lovers’ memories, it’s only natural to look at what other amazing music festivals might be looming in the future. Destino Ranch comes to mind. A new project focused on becoming an international destination where nature and technology combine to create unforgettable…

TuesdayMay 07, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, through its patented DehydraTECH(TM) technology, looks to address the growing type 2 diabetes and obesity problem Given the success of previous studies, the company is looking to double down on glucagon-like peptide 1 (“GLP-1”) studies for 2024 GLP-1 treatments are a major player in managing weight and addressing diabetes, and Lexaria’s DehydraTECH(TM) drug delivery platform has the potential of replacing painful and expensive GLP-1 injections with an effective oral delivery path The company has already received independent ethics review board approval for its GLP-1 human pilot study #2, a milestone that brings…

ThursdayMay 02, 2024 10:00 am

California Moves to Shield Youth Against Illicit Hemp Products

Last week, Governor Gavin Newsom of California directed the state’s Department of Alcoholic Beverage Control and the Department of Public Health to issue notices on the distribution and sale of illicit hemp products. This comes after it was determined that youth in the state can be exposed to intoxicating drugs through illicit hemp products. The objective of these notices is to ensure that laws are complied with, to protect the youth and others in the state from possibly harmful hemp-infused products while restricting their access to those products. In his statement, Governor Newsom explained that misleading and mislabelled products didn’t…

TuesdayApr 30, 2024 10:00 am

Canadian Researchers Want to Obtain Lyocell from Hemp

Scientists at the University of Alberta are looking into how hemp grown in Canada can be utilized in the production of lyocell. Lyocell is a fiber commonly used as a substitute for silk or cotton. This semisynthetic fabric is hypoallergenic, soft to the touch and cling free. Lyocell, which has cellulose as its primary ingredient, was developed by scientists who hoped to manufacture rayon in a technique less harmful than the viscose procedure. Wood is lyocell’s main feedstock; common types of wood include oak, birch and eucalyptus. Now scientists believe hemp holds the potential for use as lyocell feedstock. The…